158 related articles for article (PubMed ID: 21519331)
1. c-fms blockade reverses glomerular macrophage infiltration and halts development of crescentic anti-GBM glomerulonephritis in the rat.
Han Y; Ma FY; Tesch GH; Manthey CL; Nikolic-Paterson DJ
Lab Invest; 2011 Jul; 91(7):978-91. PubMed ID: 21519331
[TBL] [Abstract][Full Text] [Related]
2. Blockade of the c-Jun amino terminal kinase prevents crescent formation and halts established anti-GBM glomerulonephritis in the rat.
Ma FY; Flanc RS; Tesch GH; Bennett BL; Friedman GC; Nikolic-Paterson DJ
Lab Invest; 2009 Apr; 89(4):470-84. PubMed ID: 19188913
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinase-12 deficiency attenuates experimental crescentic anti-glomerular basement membrane glomerulonephritis.
Abraham AP; Ma FY; Mulley WR; Nikolic-Paterson DJ; Tesch GH
Nephrology (Carlton); 2018 Feb; 23(2):183-189. PubMed ID: 27862656
[TBL] [Abstract][Full Text] [Related]
4. Antibodies to intercellular adhesion molecule 1/lymphocyte function-associated antigen 1 prevent crescent formation in rat autoimmune glomerulonephritis.
Nishikawa K; Guo YJ; Miyasaka M; Tamatani T; Collins AB; Sy MS; McCluskey RT; Andres G
J Exp Med; 1993 Mar; 177(3):667-77. PubMed ID: 8094735
[TBL] [Abstract][Full Text] [Related]
5. Role of macrophages in the fibrotic phase of rat crescentic glomerulonephritis.
Han Y; Ma FY; Tesch GH; Manthey CL; Nikolic-Paterson DJ
Am J Physiol Renal Physiol; 2013 Apr; 304(8):F1043-53. PubMed ID: 23408165
[TBL] [Abstract][Full Text] [Related]
6. Important role for macrophages in induction of crescentic anti-GBM glomerulonephritis in WKY rats.
Isome M; Fujinaka H; Adhikary LP; Kovalenko P; El-Shemi AG; Yoshida Y; Yaoita E; Takeishi T; Takeya M; Naito M; Suzuki H; Yamamoto T
Nephrol Dial Transplant; 2004 Dec; 19(12):2997-3004. PubMed ID: 15574997
[TBL] [Abstract][Full Text] [Related]
7. An inhibitor of spleen tyrosine kinase suppresses experimental crescentic glomerulonephritis.
Han Y; Ma FY; Di Paolo J; Nikolic-Paterson DJ
Int J Immunopathol Pharmacol; 2018; 32():2058738418783404. PubMed ID: 29923438
[TBL] [Abstract][Full Text] [Related]
8. ANG II receptor blockade enhances anti-inflammatory macrophages in anti-glomerular basement membrane glomerulonephritis.
Aki K; Shimizu A; Masuda Y; Kuwahara N; Arai T; Ishikawa A; Fujita E; Mii A; Natori Y; Fukunaga Y; Fukuda Y
Am J Physiol Renal Physiol; 2010 Apr; 298(4):F870-82. PubMed ID: 20071465
[TBL] [Abstract][Full Text] [Related]
9. TNF-alpha up-regulates renal MIF expression in rat crescentic glomerulonephritis.
Lan HY; Yang N; Metz C; Mu W; Song Q; Nikolic-Paterson DJ; Bacher M; Bucala R; Atkins RC
Mol Med; 1997 Feb; 3(2):136-44. PubMed ID: 9085256
[TBL] [Abstract][Full Text] [Related]
10. Pentoxifylline suppresses renal tumour necrosis factor-alpha and ameliorates experimental crescentic glomerulonephritis in rats.
Chen YM; Ng YY; Lin SL; Chiang WC; Lan HY; Tsai TJ
Nephrol Dial Transplant; 2004 May; 19(5):1106-15. PubMed ID: 14993492
[TBL] [Abstract][Full Text] [Related]
11. ASK1 inhibitor treatment suppresses p38/JNK signalling with reduced kidney inflammation and fibrosis in rat crescentic glomerulonephritis.
Amos LA; Ma FY; Tesch GH; Liles JT; Breckenridge DG; Nikolic-Paterson DJ; Han Y
J Cell Mol Med; 2018 Sep; 22(9):4522-4533. PubMed ID: 29998485
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-4 ameliorates crescentic glomerulonephritis in Wistar Kyoto rats.
Cook HT; Singh SJ; Wembridge DE; Smith J; Tam FW; Pusey CD
Kidney Int; 1999 Apr; 55(4):1319-26. PubMed ID: 10200996
[TBL] [Abstract][Full Text] [Related]
13. Preventive effect of sulphated colominic acid on P-selectin-dependent infiltration of macrophages in experimentally induced crescentic glomerulonephritis.
Ogawa D; Shikata K; Matsuda M; Okada S; Wada J; Yamaguchi S; Suzuki Y; Miyasaka M; Tojo S; Makino H
Clin Exp Immunol; 2002 Jul; 129(1):43-53. PubMed ID: 12100021
[TBL] [Abstract][Full Text] [Related]
14. Local macrophage proliferation in the pathogenesis of glomerular crescent formation in rat anti-glomerular basement membrane (GBM) glomerulonephritis.
Lan HY; Nikolic-Paterson DJ; Mu W; Atkins RC
Clin Exp Immunol; 1997 Nov; 110(2):233-40. PubMed ID: 9367407
[TBL] [Abstract][Full Text] [Related]
15. Effect of interleukin-10 treatment on crescentic glomerulonephritis in rats.
Chadban SJ; Tesch GH; Lan HY; Atkins RC; Nikolic-Paterson DJ
Kidney Int; 1997 Jun; 51(6):1809-17. PubMed ID: 9186870
[TBL] [Abstract][Full Text] [Related]
16. Antibody blockade of TNF-alpha reduces inflammation and scarring in experimental crescentic glomerulonephritis.
Khan SB; Cook HT; Bhangal G; Smith J; Tam FW; Pusey CD
Kidney Int; 2005 May; 67(5):1812-20. PubMed ID: 15840028
[TBL] [Abstract][Full Text] [Related]
17. Suppression of experimental crescentic glomerulonephritis by interleukin-10 gene transfer.
El-Shemi AG; Fujinaka H; Matsuki A; Kamiie J; Kovalenko P; Qu Z; Bilim V; Nishimoto G; Yaoita E; Yoshida Y; Anegon I; Yamamoto T
Kidney Int; 2004 Apr; 65(4):1280-9. PubMed ID: 15086467
[TBL] [Abstract][Full Text] [Related]
18. Treatment with a cyclin-dependent kinase inhibitor, seliciclib, is effective in reducing glomerular macrophage numbers and the severity of established experimental glomerulonephritis.
Sheryanna AM; Smith J; Bhangal G; Barnett A; McClue S; Tam FW; Cook T; Pusey CD
Nephrology (Carlton); 2011 May; 16(4):410-6. PubMed ID: 21518118
[TBL] [Abstract][Full Text] [Related]
19. Suppression of experimental crescentic glomerulonephritis by deoxyspergualin.
Lan HY; Zarama M; Nikolic-Paterson DJ; Kerr PG; Atkins RC
J Am Soc Nephrol; 1993 May; 3(11):1765-74. PubMed ID: 8329671
[TBL] [Abstract][Full Text] [Related]
20. Prevention of glomerular crescent formation in glomerulonephritis by mycophenolate mofetil in rats.
Takeda S; Takahashi M; Sado Y; Takeuchi K; Hakamata Y; Shimizu H; Kaneko T; Yamamoto H; Ito C; Ookawara S; Asano Y; Kusano E; Kobayashi E
Nephrol Dial Transplant; 2004 Sep; 19(9):2228-36. PubMed ID: 15238626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
